Ganglioglioma in a Survivor of Infantile Glioblastoma.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 25 1 2019
medline: 1 7 2020
entrez: 25 1 2019
Statut: ppublish

Résumé

Congenital tumors account for 2% to 4% of all pediatric central nervous system tumors. Glioblastoma multiforme (GBM) represents a small subset of these tumors. Despite harboring histologic features similar to older patients, infants with GBM exhibit improved survival and respond more favorably to surgery and chemotherapy. To highlight this tumor's unique behavior, we report the case of a survivor of infantile GBM who developed a recurrent tumor in the surgical bed 6 months after diagnosis. The tumor was ultimately resected and was a ganglioglioma. This case shows both a favorable clinical outcome to an infantile GBM and this tumor's natural history.

Identifiants

pubmed: 30676438
doi: 10.1097/MPH.0000000000001417
pii: 00043426-202001000-00028
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e56-e60

Références

El-Ayadi M, Ansari M, Sturm D, et al. High-grade glioma in very young children: a rare and particular patient population. Oncotarget. 2017;8:64564–64578.
Prasad V, Rajesh A, Purohit A, et al. A rare case of congenital glioblastoma with atypical presentation in an eleven month-old infant: case report with review of literature. Asian J Neurosurg. 2017;12:72–74.
Brat DJ, Shehata BM, Castellano-Sanchez AA, et al. Congenital glioblastoma: a clinicopathologic and genetic analysis. Brain Pathol. 2007;17:276–281.
Hou LC, Bababeygy SR, Sarkissian V, et al. Congenital glioblastoma multiforme: case report and review of the literature. Pediatr Neurosurg. 2008;44:304–312.
Macy ME, Birks DK, Barton VN, et al. Clinical and molecular characteristics of congenital glioblastoma. Neuro-Oncology. 2012;14:931–941.
Kameda M, Otani Y, Ichikawa T, et al. Congenital glioblastoma with distinct clinical and molecular characteristics: case reports and a literature review. World Neurosurg. 2017;101:817.e5–817.e14.
Khalatbari MR, Hamidi M, Moharamzad Y. Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature. Childs Nerv Syst. 2011;27:1347–1352.
Kotecha RS, Katy B, Junckerstorff RC, et al. Chemotherapy increases amenability of surgical resection in congenital glioblastoma. Pediatr Hematol Oncol. 2012;29:538–544.
Sanders RP, Kocak M, Burger PC, et al. High-grade astrocytoma in very young children. Pediatr Blood Cancer. 2007;49:888–893.
Gielen GH, Gessi M, Buttarelli FR, et al. Genetic analysis of diffuse high-grade astrocytomas in infancy defines a novel molecular entity. Brain Pathol. 2014;25:409–417.
Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469–474.
Cohen KJ, Pollack IF, Zhou T, et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Childrens Oncology Group. Neuro Oncol. 2011;13:317–323.
Jeibmann A, Hasselblatt M, Pfister S, et al. From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior. J Neurosurg Pediatr. 2009;4:475–478.
Yang MMH, Biotech M, Singhal A, et al. Possible differentiation of cerebral glioblastoma into pleomorphic xanthoastrocytoma: an unusual case in an infant. J Neurosurg Pediatr. 2012;9:517–523.
Davis T, Doyle H, Tobias V, et al. Case report of spontaneous resolution of a congenital glioblastoma. Pediatrics. 2016;137:e20151241.
Korshunov A, Ryzhova M, Hovestadt V, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol. 2015;29:669–678.
Strum D, Bender S, Jones DTW, et al. Paediatric and adult glioblastoma: multiforme (epi)genomic culprits emerge. Nat Rev Cancer. 2014;14:92–107.
Cocce MC, Mardin BR, Bens S, et al. Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3). Genes Chromosomes Cancer. 2016;55:677–687.
Wu G, Diaz A, Paugh B, et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high grade glioma. Nat Genet. 2014;46:444–450.
Nsir AB, Darmoul M, Hadhri R, et al. Congenital glioblastoma: lessons learned from a rare case with unusual presentation. Turk Neurosurg. 2017;27:464–467.

Auteurs

Amanda Scheuermann (A)

Departments of Pediatrics.

Meghan Belongia (M)

Departments of Pediatrics.
Division of Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI.

Michael W Lawlor (MW)

Pathology and Laboratory Medicine.

Mariko Suchi (M)

Pathology and Laboratory Medicine.

Bruce Kaufman (B)

Neurosurgery.

Varshini Vasudevaraja (V)

Department of Pathology, New York University, New York, NY.

Jonathan Serrano (J)

Department of Pathology, New York University, New York, NY.

Matija Snuderl (M)

Department of Pathology, New York University, New York, NY.

Jeffrey Knipstein (J)

Departments of Pediatrics.
Division of Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH